• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry).

作者信息

Glace Baptiste, Gottenberg Jacques-Eric, Mariette Xavier, Philippe Ravaud, Pereira Bruno, Lequerré Thierry, Berthelot Jean-Marie, Dougados Maxime, Toussirot Eric, Pham Thao, Allanore Yannick, Loeuille Damien, Euller-Ziegler Liana, Soubrier Martin

出版信息

Ann Rheum Dis. 2012 Aug;71(8):1429-31. doi: 10.1136/annrheumdis-2011-200915. Epub 2012 Apr 13.

DOI:10.1136/annrheumdis-2011-200915
PMID:22504557
Abstract
摘要

相似文献

1
Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry).利妥昔单抗治疗肺部类风湿结节的疗效：来自法国自身免疫与利妥昔单抗/类风湿关节炎注册研究（AIR/PR注册研究）的10例患者的研究结果
Ann Rheum Dis. 2012 Aug;71(8):1429-31. doi: 10.1136/annrheumdis-2011-200915. Epub 2012 Apr 13.
2
[Regression of peripheral and pulmonary rheumatoid nodules under therapy with rituximab].[利妥昔单抗治疗下外周及肺部类风湿结节的消退]
Z Rheumatol. 2013 Mar;72(2):166-71. doi: 10.1007/s00393-012-1054-0.
3
Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF-α therapy.利妥昔单抗对类风湿关节炎患者在抗TNF-α治疗期间出现或增大的肺部结节病的疗效。
Clin Exp Rheumatol. 2011 Jul-Aug;29(4):752-3. Epub 2011 Sep 1.
4
[Favorable response of pulmonary rheumatoid nodule to Rituximab].
Z Rheumatol. 2009 Jun;68(4):343-4. doi: 10.1007/s00393-009-0435-5.
5
Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α.对抗肿瘤坏死因子-α有反应的日本类风湿性关节炎患者中抗环瓜氨酸肽抗体水平的降低
Mod Rheumatol. 2010 Oct;20(5):528-30. doi: 10.1007/s10165-010-0305-7. Epub 2010 May 12.
6
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.利妥昔单抗治疗类风湿关节炎自身抗体阳性患者和 TNF 拮抗剂治疗失败患者的最高临床疗效：来自 10 个欧洲登记处的汇总数据。
Ann Rheum Dis. 2011 Sep;70(9):1575-80. doi: 10.1136/ard.2010.148759. Epub 2011 May 12.
7
Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.炎症和自身抗体标志物可识别出在接受利妥昔单抗治疗后临床获益增强的类风湿关节炎患者。
Arthritis Rheum. 2011 Dec;63(12):3681-91. doi: 10.1002/art.30596.
8
Smoking, rheumatoid factor status and responses to rituximab.吸烟、类风湿因子状态与对利妥昔单抗的反应
Ann Rheum Dis. 2012 Sep;71(9):1587-8. doi: 10.1136/annrheumdis-2012-201758. Epub 2012 Apr 24.
9
Knee tuberculosis under rituximab therapy for rheumatoid arthritis.利妥昔单抗治疗类风湿关节炎过程中出现的膝关节结核
Joint Bone Spine. 2013 Jul;80(4):435-6. doi: 10.1016/j.jbspin.2012.10.018. Epub 2012 Dec 11.
10
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.评论：类风湿关节炎中，类风湿因子阳性而非抗环瓜氨酸肽抗体阳性、较低的残疾程度以及较少的抗 TNF 药物治疗失败与对利妥昔单抗的反应相关。
Rheumatology (Oxford). 2010 Sep;49(9):1795-6; author reply 1796-7. doi: 10.1093/rheumatology/keq141. Epub 2010 May 19.

引用本文的文献

1
ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis.抗环瓜氨酸肽抗体（ACPA）是类风湿关节炎患者经CT证实的肺结节进展的主要危险因素。
Clin Rheumatol. 2025 Mar;44(3):1031-1040. doi: 10.1007/s10067-025-07344-9. Epub 2025 Jan 30.
2
Outcome of solid and cavitary pulmonary nodules in rheumatoid arthritis patients-case series.类风湿关节炎患者实性和空洞性肺结节的转归——病例系列研究。
Turk J Med Sci. 2022 Apr;52(5):1713-1720. doi: 10.55730/1300-0144.5514. Epub 2022 Oct 19.
3
Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report.
Rheumatol Int. 2023 Mar;43(3):533-536. doi: 10.1007/s00296-022-05220-2. Epub 2022 Nov 1.
4
Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients.使用生物性改善病情抗风湿药（DMARDs）进行治疗可能不会对类风湿关节炎患者的肺结节产生不利影响。
Eur J Rheumatol. 2022 Apr;9(2):75-81. doi: 10.5152/eujrheum.2022.21067.
5
Thoracic Manifestations of Rheumatoid Arthritis.类风湿关节炎的胸部表现。
Clin Chest Med. 2019 Sep;40(3):545-560. doi: 10.1016/j.ccm.2019.05.003. Epub 2019 Jul 6.
6
Multiple pulmonary nodules in rheumatoid arthritis.类风湿关节炎中的多发性肺结节。
Eur J Rheumatol. 2018 Oct 31;6(4):228. doi: 10.5152/eurjrheum.2018.18049.
7
Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy.类风湿肺结节：临床和影像学特征与恶性肿瘤的比较。
Eur Radiol. 2019 Apr;29(4):1684-1692. doi: 10.1007/s00330-018-5755-x. Epub 2018 Oct 4.
8
Case 238: Spontaneous Pneumothorax Secondary to Intrapulmonary Necrobiotic Rheumatoid Nodule.病例238：肺内坏死性类风湿结节继发自发性气胸。
Radiology. 2017 Feb;282(2):602-608. doi: 10.1148/radiol.2016150224.
9
Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview.用于慢性免疫介导疾病的肿瘤坏死因子-α阻断剂及其他生物制剂下的反常反应：分析性与综合性概述
RMD Open. 2016 Jul 15;2(2):e000239. doi: 10.1136/rmdopen-2015-000239. eCollection 2016.
10
Occurrence of pulmonary rheumatoid nodules following biological therapies.
Clin Rheumatol. 2015 Sep;34(9):1639-42. doi: 10.1007/s10067-014-2789-6. Epub 2014 Sep 30.